• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二尖瓣经皮缘对缘修复术患者体重过轻的预后影响:OCEAN-Mitral注册研究

Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN-Mitral registry.

作者信息

Higuchi Ryosuke, Izumo Masaki, Izumi Yuki, Saji Mike, Isobe Mitsuaki, Akashi Yoshihiro, Yamamoto Masanori, Asami Masahiko, Enta Yusuke, Nakashima Masaki, Shirai Shinichi, Mizuno Shingo, Watanabe Yusuke, Amaki Makoto, Kodama Kazuhisa, Yamaguchi Junichi, Naganuma Toru, Bota Hiroki, Ohno Yohei, Yamawaki Masahiro, Ueno Hiroshi, Mizutani Kazuki, Kubo Shunsuke, Otsuka Toshiaki, Hayashida Kentaro

机构信息

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Division of Cardiology, St. Marianna University School of Medicine Hospital, Kawasaki, Japan.

出版信息

ESC Heart Fail. 2025 Feb;12(1):408-417. doi: 10.1002/ehf2.15047. Epub 2024 Sep 23.

DOI:10.1002/ehf2.15047
PMID:39308333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769672/
Abstract

AIMS

Mitral transcatheter edge-to-edge repair (M-TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M-TEER candidates for effective patient selection, optimal periprocedural care and improved long-term outcomes. The body mass index (BMI) is a simple and practical prognostic index, and the obesity paradox has been widely reported.

METHODS AND RESULTS

Between April 2018 and June 2021, 2149 patients undergoing M-TEER were registered in the prospective multicentre registry and classified into three groups: underweight (BMI < 18.5 kg/m), normal weight (18.5 ≤ BMI < 25 kg/m) and overweight and obese (25 kg/m ≦ BMI) [Correction added on 17 October 2024, after first online publication: In the preceding sentence, "18.5 ☆ BMI < 25 kg/m2" and "25 kg/m2 ☆ BMI" have been corrected to "18.5 ≤ BMI < 25 kg/m2" and "25 kg/m2  ≦  BMI" in this version.] The impact of underweight on the all-cause, cardiovascular and non-cardiovascular mortality following M-TEER was evaluated [follow-up duration: 436 (363-733) days]. The participants (median BMI: 21.1 kg/m) were categorized as underweight (n = 450, 20.9%), normal weight (n = 1409, 65.6%) and overweight and obese (n = 290, 13.5%). Compared with the other two groups, the underweight group exhibited several negative prognostic factors, including older age, frailty, no dyslipidaemia, hypoalbuminaemia, residual MR and non-home discharge. Underweight patients had the highest rate of all-cause, cardiovascular and non-cardiovascular mortality, whereas those in the other two groups were similar. As per the multivariate analysis, underweight itself was associated with all-cause mortality (hazard ratio: 1.52, 95% confidence interval: 1.17-1.97, P = 0.009) and cardiovascular mortality (hazard ratio: 1.45, 95% confidence interval: 1.04-2.01, P = 0.028).

CONCLUSIONS

Underweight patients had the highest mortality rate after M-TEER. Comorbidities, residual MR, discharge disposition and underweight status were correlated with postprocedural outcome.

摘要

目的

二尖瓣经导管缘对缘修复术(M-TEER)是治疗严重二尖瓣反流(MR)的有效方法,需要对M-TEER候选者进行准确的风险分层,以实现有效的患者选择、优化围手术期护理并改善长期预后。体重指数(BMI)是一个简单实用的预后指标,肥胖悖论已被广泛报道。

方法与结果

2018年4月至2021年6月期间,2149例行M-TEER的患者被纳入前瞻性多中心注册研究,并分为三组:体重过轻(BMI<18.5kg/m²)、正常体重(18.5≤BMI<25kg/m²)和超重及肥胖(BMI≥25kg/m²)[2024年10月17日首次在线发表后更正:在上一句中,“18.5☆BMI<25kg/m²”和“25kg/m²☆BMI”在本版本中已更正为“18.5≤BMI<25kg/m²”和“25kg/m² ≦ BMI”]。评估体重过轻对M-TEER术后全因、心血管和非心血管死亡率的影响[随访时间:436(363 - 733)天]。参与者(BMI中位数:21.1kg/m²)被分类为体重过轻(n = 450,20.9%)、正常体重(n = 1409,65.6%)和超重及肥胖(n = 290,13.5%)。与其他两组相比,体重过轻组表现出几个不良预后因素,包括年龄较大、身体虚弱、无血脂异常、低白蛋白血症、残余MR和非家庭出院。体重过轻的患者全因、心血管和非心血管死亡率最高,而其他两组患者的死亡率相似。多因素分析显示,体重过轻本身与全因死亡率(风险比:1.52,95%置信区间:1.17 - 1.97,P = 0.009)和心血管死亡率(风险比:1.45,95%置信区间:1.04 - 2.01,P = 0.028)相关。

结论

体重过轻的患者在M-TEER术后死亡率最高。合并症、残余MR、出院处置和体重过轻状态与术后结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb54/11769672/da2c7bc76893/EHF2-12-408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb54/11769672/b5455206cb76/EHF2-12-408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb54/11769672/da2c7bc76893/EHF2-12-408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb54/11769672/b5455206cb76/EHF2-12-408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb54/11769672/da2c7bc76893/EHF2-12-408-g003.jpg

相似文献

1
Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN-Mitral registry.二尖瓣经皮缘对缘修复术患者体重过轻的预后影响:OCEAN-Mitral注册研究
ESC Heart Fail. 2025 Feb;12(1):408-417. doi: 10.1002/ehf2.15047. Epub 2024 Sep 23.
2
Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.体重过轻与 MitraClip 植入后的短期和长期预后不良相关:来自德国经导管二尖瓣介入治疗(TRAMI)注册研究的结果。
Am Heart J. 2020 Apr;222:73-82. doi: 10.1016/j.ahj.2019.12.022. Epub 2020 Jan 10.
3
Low body mass index and risk of mortality after mitral transcatheter edge-to-edge repair procedure: The "obesity paradox".低体重指数与二尖瓣经导管缘对缘修复术后死亡率的关系:“肥胖悖论”。
Catheter Cardiovasc Interv. 2024 Aug;104(2):401-407. doi: 10.1002/ccd.31114. Epub 2024 May 31.
4
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry.缘对缘修复二尖瓣反流的长期结果:EuroSMR 注册研究的 5 年结果。
JACC Cardiovasc Interv. 2024 Nov 11;17(21):2543-2554. doi: 10.1016/j.jcin.2024.08.016.
5
Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.按改良纳入标准分层的二尖瓣缘对缘修复术后结局。
J Am Coll Cardiol. 2021 Dec 14;78(24):2408-2421. doi: 10.1016/j.jacc.2021.10.011.
6
Mismatch Between Residual Mitral Regurgitation and Left Atrial Pressure Predicts Prognosis After Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术后残余二尖瓣反流与左心房压力不匹配预测预后。
JACC Cardiovasc Interv. 2024 Sep 23;17(18):2126-2137. doi: 10.1016/j.jcin.2024.07.046.
7
Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.经导管缘对缘二尖瓣修复术后β受体阻滞剂滴定对继发性二尖瓣反流患者的影响:OCEAN-二尖瓣注册研究。
Int J Cardiol. 2025 Jan 1;418:132595. doi: 10.1016/j.ijcard.2024.132595. Epub 2024 Sep 24.
8
Technical and Clinical Outcomes After Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Male and Female Patients: Is Equality Achieved?经导管缘对缘修复术治疗男性和女性二尖瓣反流的技术和临床转归:是否实现了平等?
J Am Heart Assoc. 2024 Jun 4;13(11):e032706. doi: 10.1161/JAHA.123.032706. Epub 2024 May 28.
9
Intraprocedural Residual Mitral Regurgitation and Survival After Transcatheter Edge-to-Edge Repair: Prospective German Multicenter Registry (MITRA-PRO).经导管缘对缘修复术后即刻残余二尖瓣反流与生存:前瞻性德国多中心注册研究(MITRA-PRO)。
JACC Cardiovasc Interv. 2023 Mar 13;16(5):574-585. doi: 10.1016/j.jcin.2022.12.015.
10
Mitral valve transcatheter edge-to-edge repair in the elderly-A safe and effective therapy.老年二尖瓣经导管缘对缘修复术——一种安全有效的治疗方法。
ESC Heart Fail. 2025 Jun;12(3):1663-1675. doi: 10.1002/ehf2.15177. Epub 2024 Dec 4.

引用本文的文献

1
The prognostic value of small psoas muscle area in patients undergoing mitral transcatheter edge-to-edge repair.小腰大肌面积在接受二尖瓣经导管缘对缘修复患者中的预后价值。
Cardiovasc Interv Ther. 2025 Jul 2. doi: 10.1007/s12928-025-01156-z.

本文引用的文献

1
Cardiac Damage in Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Edge-to-Edge Repair.经导管二尖瓣瓣环成形术治疗退行性二尖瓣反流中的心脏损伤。
Circ Cardiovasc Interv. 2024 Jun;17(6):e013794. doi: 10.1161/CIRCINTERVENTIONS.123.013794. Epub 2024 Apr 17.
2
Update on obesity, the obesity paradox, and obesity management in heart failure.心力衰竭中肥胖、肥胖悖论和肥胖管理的最新进展。
Prog Cardiovasc Dis. 2024 Jan-Feb;82:34-42. doi: 10.1016/j.pcad.2024.01.003. Epub 2024 Jan 9.
3
Short-Term Outcomes Following Transcatheter Edge-to-Edge Repair: Insights From the OCEAN-Mitral Registry.
经导管缘对缘修复术后的短期结果:来自OCEAN-二尖瓣注册研究的见解
JACC Asia. 2023 Aug 29;3(5):766-773. doi: 10.1016/j.jacasi.2023.06.008. eCollection 2023 Oct.
4
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.1990 - 2022年心血管疾病及其风险的全球负担
J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007.
5
Outcomes of Octogenarians and Nonagenarians in a Contemporary Cardiac Care Unit - Insights From 2,242 Patients Admitted Between 2019 and 2021.当代心脏护理病房中八旬和九旬老人的治疗结果——来自2019年至2021年收治的2242例患者的见解
Circ Rep. 2023 Oct 18;5(11):430-436. doi: 10.1253/circrep.CR-23-0078. eCollection 2023 Nov 10.
6
One-Year Outcomes and Their Relationship to Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair With MitraClip Device: Insights From the OCEAN-Mitral Registry.经导管缘对缘修复二尖瓣器械 MitraClip 治疗后一年的结果及其与残余二尖瓣反流的关系:来自 OCEAN-Mitral 注册研究的见解。
J Am Heart Assoc. 2023 Oct 17;12(20):e030747. doi: 10.1161/JAHA.123.030747. Epub 2023 Oct 10.
7
Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair.经导管缘对缘修复术后三尖瓣反流患者体重指数的影响。
Clin Res Cardiol. 2024 Jan;113(1):156-167. doi: 10.1007/s00392-023-02312-2. Epub 2023 Oct 4.
8
Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.经导管缘对缘修复术治疗 5000 例继发性二尖瓣反流患者:COAPT 上市后研究。
J Am Coll Cardiol. 2023 Sep 26;82(13):1281-1297. doi: 10.1016/j.jacc.2023.07.015.
9
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair: 30-Day Results From EXPAND G4.第四代二尖瓣经导管修复的真实世界结局:EXPAND G4 的 30 天结果。
JACC Cardiovasc Interv. 2023 Jun 26;16(12):1463-1473. doi: 10.1016/j.jcin.2023.05.013.
10
Sarcopenia and Cardiovascular Diseases.肌肉减少症与心血管疾病
Circulation. 2023 May 16;147(20):1534-1553. doi: 10.1161/CIRCULATIONAHA.123.064071. Epub 2023 May 15.